Stemline Therapeutics Reports Third Quarter 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
Stemline Therapeutics (STML) Tops Q3 EPS by 6c
November 6, 2015 8:04 AM ESTStemline Therapeutics (NASDAQ: STML) reported Q3 EPS of ($0.53), $0.06 better than the analyst estimate of ($0.59).
For earnings history and earnings-related data on Stemline Therapeutics (STML) click here.
... More